Xiao-Meng Li
Overview
Explore the profile of Xiao-Meng Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
579
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gong D, Li W, Li X, Wan C, Zhou Y, Wang S, et al.
Int J Ophthalmol
. 2024 Dec;
17(12):2308-2315.
PMID: 39697896
This paper analyzes the current status, technological developments, academic exchange platforms, and future challenges and solutions in the field of intelligent ophthalmology (IO) in China. In terms of technology, significant...
2.
Yang X, Li X, Ingvarsson P, Xi C, Liao W
BMC Plant Biol
. 2024 Nov;
24(1):1106.
PMID: 39567881
Background: Ambrosia artemisiifolia is a highly invasive herb with deleterious effects on public health and agricultural systems. Flowering time in this species has been reported to vary along a latitudinal...
3.
Cheng Z, Chen G, Li X, Ren H
Sensors (Basel)
. 2024 Nov;
24(21).
PMID: 39517783
Due to its vulnerability to a variety of cyber attacks, research on cyber security for power systems has become especially crucial. In order to maintain the safe and stable operation...
4.
Li Y, Li X, Wei L, Ye J
Front Immunol
. 2024 Nov;
15:1451989.
PMID: 39483479
In recent decades, nanotechnology has significantly advanced drug delivery systems, particularly in targeting subcellular organelles, thus opening new avenues for disease treatment. Mitochondria, critical for cellular energy and health, when...
5.
Li Y, Li X, Yang K, Tong W
Front Immunol
. 2024 Jun;
15:1402862.
PMID: 38863706
Ovarian cancer, ranking as the seventh most prevalent malignancy among women globally, faces significant challenges in diagnosis and therapeutic intervention. The difficulties in early detection are amplified by the limitations...
6.
Li Y, Li X, Duan H, Yang K, Ye J
Front Immunol
. 2024 May;
15:1398652.
PMID: 38779682
In the advancement of Inflammatory Bowel Disease (IBD) treatment, existing therapeutic methods exhibit limitations; they do not offer a complete cure for IBD and can trigger adverse side effects. Consequently,...
7.
Huang S, Ran Q, Li X, Bao X, Zheng C, Li X
Proc Natl Acad Sci U S A
. 2024 May;
121(21):e2319060121.
PMID: 38753516
Multicellular organisms are composed of many tissue types that have distinct morphologies and functions, which are largely driven by specialized proteomes and interactomes. To define the proteome and interactome of...
8.
Su B, Li X, Huang Z, Wang Y, Shao J, Xu Y, et al.
Ecotoxicol Environ Saf
. 2024 Apr;
276:116277.
PMID: 38604061
Ochratoxin A (OTA) is a common fungal toxin frequently detected in food and human plasma samples. Currently, the physiologically based toxicokinetic (PBTK) model plays an active role in dose translation...
9.
Li Y, Yang K, Kong D, Li X, Duan H, Ye J
Front Immunol
. 2024 Feb;
14:1343788.
PMID: 38299142
Stroke poses a critical global health challenge, leading to substantial morbidity and mortality. Existing treatments often miss vital timeframes and encounter limitations due to adverse effects, prompting the pursuit of...
10.
Huang Y, Yi J, Song J, Du L, Li X, Cheng L, et al.
Ann Clin Microbiol Antimicrob
. 2023 Nov;
22(1):102.
PMID: 37986091
Objective: The current study evaluated the diagnostic performance of serum (1,3)-beta-D Glucan (BDG) in differentiating PJP from P. jirovecii-colonization in HIV-uninfected patients with P. jirovecii PCR-positive results. Methods: This was...